Keiko Katsumi

Title: Keiko Katsumi: Innovator in Antibody Research

Introduction

Keiko Katsumi is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of antibody research, particularly in the development of anti-cadherin antibodies. With a total of 3 patents, her work focuses on innovative solutions for cancer treatment.

Latest Patents

One of her latest patents is an anti-CDH3 antibody having high internalization capacity. This invention aims to provide an anti-cadherin antibody that effectively kills cadherin-expressing cancer cells. The antibody recognizes a cadherin domain 1 (EC1) and exhibits a high internalization capacity. Another notable patent is for a highly effective anti-cadherin antibody for the induction of antibody-dependent cellular cytotoxicity in vivo. This invention provides an anti-cadherin antibody that recognizes regions of cadherin domains, achieving an antibody-dependent cellular cytotoxicity of 30% or more at an antibody concentration of 1 µg/mL.

Career Highlights

Throughout her career, Keiko Katsumi has worked with notable organizations such as Perseus Proteomics Inc. and The University of Tokyo. Her research has significantly advanced the understanding and application of antibodies in medical science.

Collaborations

Keiko has collaborated with esteemed colleagues, including Keisuke Ishii and Katsushi Kouda. These partnerships have further enriched her research and innovation in the field.

Conclusion

Keiko Katsumi is a trailblazer in antibody research, with her innovative patents paving the way for advancements in cancer treatment. Her contributions continue to impact the scientific community and improve therapeutic options for patients.